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The SGK3-triggered ubiquitin–proteasome
degradation of podocalyxin (PC) and ezrin
in podocytes was associated with the
stability of the PC/ezrin complex
Ya-Pei Yuan1, Hong Zhao2, Li-Qin Peng1,3, Zi-Fang Li1, Song Liu1, Cheng-Yan Yuan1, Mercy-Julian Mwamunyi1,
David Pearce4,5 and Li-Jun Yao1
Abstract
Podocyte damage is commonly accompanied by destabilization of the podocalyxin (PC)/ezrin complex. Serum- and
glucocorticoid-inducible kinase 3 (SGK3) plays a role in the maintenance of podocyte function, but the details of this
role are poorly understood. Herein we demonstrated that SGK3 and its downstream target protein neural precursor
cell expressed developmentally downregulated protein 4 subtype 2 (Nedd4-2) triggered PC and ezrin interaction. In
adriamycin (ADR)-induced nephritic mice, and after puromycin aminonucleoside (PAN)-induced podocyte damage
in vitro, PC and ezrin protein expression levels decreased significantly, while Nedd4-2 activity increased. Moreover, PAN
treatment increased PC and ezrin ubiquitination and decreased PC/ezrin interaction in cultured mouse podocytes. The
downregulation of SGK3 activity in mouse podocytes resulted in decreased PC and ezrin protein expression and
increased the ubiquitin–proteasome degradation of PC and ezrin. Furthermore, upregulation of SGK3 activity mostly
reversed the PAN-induced decrease in PC and ezrin protein expression. Overexpression of Nedd4-2 led to decreased
ezrin protein expression via the upregulation of ezrin ubiquitination. In contrast, Nedd4-2 knockdown resulted in
increased ezrin protein expression but decreased ezrin ubiquitination. In PC-transfected human embryonic kidney
(HEK293T) cells, SGK3 activity downregulation and Nedd4-2 overexpression resulted in decreased PC/ezrin interaction.
These results suggested that SGK3 triggers the ubiquitin–proteasome degradation of PC and ezrin, while the SGK3/
Nedd4-2 signaling pathway regulates ezrin, but not PC, ubiquitination. Thus SGK3 helps to regulate podocyte function
by maintaining the stability of the PC/ezrin complex.
Introduction
Proteinuria, an important clinical manifestation of
chronic kidney disease (CKD), may be caused by the loss
of podocyte structural protein function1–3, leading to
glomerular sclerosis and end-stage renal failure. In order
to understand pathogenesis of proteinuria and to design
therapeutic strategies to prevent the development of
proteinuric CKD, investigations of the signaling pathways
underlying podocyte damage are necessary.
We previously reported that a lack of serum- and
glucocorticoid-inducible kinase 3 (SGK3) resulted in pro-
teinuria in mice and that SGK3 activity and expression were
inhibited after podocyte damage, both in vivo and in vitro4.
Other studies have shown that the downstream target pro-
tein of SGK3, glycogen synthase kinase-3 (GSK3), is involved
in the regulation of podocytosis, proteinuria, and podocyte
autonomic injury5,6. Like AKT (also known as protein kinase
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B), SGK3 is a member of the serine–threonine protein
kinase family and is highly expressed in mammalian kidney
tissue7. Extensive studies have shown that AKT2 regulates
the survival and function of podocytes during CKD8–10.
AKT2 and SGK3 are fairly homologous in structure and
function11. Thus it is probable that SGK3 is involved in the
pathogenesis of proteinuria after podocyte damage4. How-
ever, the mechanism by which SGK3 induces podocyte
dysfunction remains poorly understood.
Podocalyxin (PC) is a heavily sialylated and sulfated
membrane protein expressed on the apical surface of glo-
merular epithelial cells (podocytes)12,13. PC is composed
of a mucin domain, a disulfide-bonded globular domain,
a transmembrane region, and a highly charged cytoplasmic
tail that has potential phosphorylation sites for protein
kinase C and casein kinase II14. This highly conserved
cytoplasmic PC tail interacts with cytoskeletal actin through
the Na+/H+ exchange Factor 2 (NHERF2)/ezrin complex
to maintain podocyte morphology, motility, and anti-
adhesion15–18. A number of studies have shown that urin-
ary PC can be used as a marker for podocyte damage19,20.
Ezrin, a member of the ezrin–radixin–moesin (ERM) pro-
tein family, maintains the stability of PC on the podocyte
membrane21,22. The deletion of the PC/ezrin complex
results in the shedding of PC from the podocyte membrane,
the disappearance of the charged filtration barrier from
the membrane, the fusing of the podocyte foot processes,
and proteinuria17. Although it has been reported that
the dissociation of the PC/ezrin complex leads to the dis-
ruption of foot process architecture23,24, the details
of the molecular mechanisms connecting PC/ezrin complex
disruption to podocyte damage remain unclear.
The neural precursor cell expressed developmentally
downregulated protein 4 subtype 2 (Nedd4-2) protein is a
downstream target of SGK37,25. Nedd4-2 is a member of
the homologous to E6-AP C-terminus (HECT) ubiquitin
(Ub) ligase E3 family and is mainly distributed in the
mammalian livers, kidneys, lungs, hearts, and brains.
Nedd4-2 binds to the PPxY (PY) motif of its target pro-
teins, recognizing and labeling target proteins with Ub
to initiate ubiquitin-mediated protein degradation26,27.
Unlike PC, ezrin has a PY motif that may bind the WW
domain of Nedd4-2. However, it is unknown whether
Nedd4-2 regulates the expression and function of ezrin
in podocytes by mediating ezrin ubiquitination. Thus
we here investigated the effects of SGK3 and the SGK3/
Nedd4-2 signaling pathway on PC and ezrin ubiquitina-
tion, as well as on PC/ezrin interaction.
Results
PC and ezrin were downregulated in the adriamycin (ADR)
mouse model
As previous studies have shown that ezrin down-
regulation or the inhibition of PC/ezrin complex
activity can lead to podocyte dysfunction28–30, we
first investigated whether the expression levels of PC
and ezrin were altered after podocyte damage in an ADR-
induced nephritic mouse model, which was established
as previously described4. By 14 days after ADR
injection, ADR-treated mice had developed significant
proteinuria in comparison with the control group
(Fig. 1a). Morphological kidney injuries were clearly
shown by periodic acid-Schiff (PAS) staining 2 weeks
after ADR injection. These injuries were characterized
by glomerular sclerotic lesions and by a tubular dilation
with an expanded lumen loaded with proteins (Fig. 1b).
Both PC and ezrin were significantly downregulated in
the kidneys of ADR mice, as compared to the control
mice (Fig. 1c). PC was highly expressed in the glomerulus
and peritubular capillaries of the mice, while ezrin was
expressed in the glomerulus and the renal tubules.
Ezrin was also known as a marker of activated or
damaged podocytes in experimental models28. PC and
ezrin expression levels, as shown by immunohistochem-
ical staining, were significantly lower in the glomeruli
of ADR mice than in the glomeruli of control mice
(Fig. 1d). Thus, consistent with previous studies30,31,
PC and ezrin were downregulated after podocyte
damage in vivo.
Puromycin aminonucleoside (PAN) treatment disrupted
the PC/ezrin interaction in cultured mouse podocytes by
inhibiting PC and ezrin protein expression
To explore PC and ezrin expression after podocyte
damage in vitro, mouse podocytes were cultured and
treated with 50 µg/ml PAN for 24 h. As demonstrated
by 3-(4, 5-dimethyl-2-thiazolyl)−2,5-diphenyl-2-H-tetra-
zolium bromide (MTT) assays and western blots,
PAN treatment reduced podocyte viability and increased
the expression of the podocyte damage maker desmin
in comparison with control cells (Fig. 2a, b). This
indicated that an in vitro PAN-induced podocyte
damage model had been successfully generated. In
addition, F-actin was distributed as parallel bundles of
stress fibers in the control podocytes; PAN treatment
destroyed these stress fibers (Fig. 2c). Reverse tran-
scriptase (RT)-PCR analysis showed that PC mRNA
expression in mouse podocytes increased significantly
after PAN treatment, as compared to untreated mouse
podocytes, while ezrin mRNA expression was unchanged
(Fig. 2d). However, PC and ezrin protein expression
levels were dramatically lower in the mouse podocytes
treated with PAN than in the control mouse podocytes
(Fig. 2e).
Because PC and ezrin are co-expressed in podocytes,
we next used confocal microscopy and co-
immunoprecipitation (Co-IP) assays to test whether
PAN regulated the PC/ezrin interaction. Confocal
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immunostaining revealed that PAN treatment decreased
interaction between PC and ezrin in cultured mouse
podocytes (Fig. 2f). Co-IP assays indicated that the
PC/ezrin interaction in mouse podocytes treated with
PAN was reduced as compared to control cells, indicating
that PAN was directly involved in the co-precipitation
of PC and ezrin (Fig. 2g). Our results therefore sugges-
ted that PAN treatment disrupted the stability of the
PC/ezrin complex, implying that the PAN-induced
decrease in PC and ezrin protein expression in mouse
podocytes might not be due to the effect of PAN on
PC and ezrin mRNA transcription.
PAN increased the ubiquitin-mediated protein degradation
of PC and ezrin in cultured mouse podocytes
The decreased protein expression of PC and ezrin
induced by PAN might be the result of increased PC
and ezrin protein degradation. To test this hypothesis,
we administered the proteasome inhibitor MG132
after PAN treatment to reduce ubiquitin-mediated pro-
tein degradation. When MG132 was added after PAN
treatment, the protein expression levels of PC and
ezrin no longer decreased (Fig. 3a). We next determined
the degree of PC and ezrin ubiquitination after PAN
treatment. As no commercial PC antibodies for Co-IP
are yet available, we transfected mouse podocytes with
a Ub-FLAG plasmid for 48 h and treated mouse
podocytes with PAN for the last 24 h of transfection.
The ubiquitination levels of PC (Fig. 3b) and ezrin
(Fig. 3c) increased remarkably in the PAN-treated mouse
podocytes as compared to the control mouse podocytes,
suggesting that ubiquitin-mediated degradation of the
PC and ezrin proteins is involved in PAN-mediated
podocyte damage.
DC Con ADR
DK071-CP
DK08-nirzE
DK63-HDPAG
BA
Con
ADR
Con ADR
PC
Ezrin
Fig. 1 The expression levels of PC and ezrin in an ADR mouse model. An intravenous injection of ADR (10.5 mg/kg) was used to induce nephritis
in the mouse model. a Urinary albumin levels, blood urea nitrogen and serum creatinine in mice at 14 days after ADR injection. Urinary albumin
excretion were presented as mg/mg of urinary creatinine. b Representative images of PAS staining micrographs show kidney injury at 2 weeks after
ADR injection in different groups of mice. Scale bar= 50 μm. c Top panel: immunoblot analysis of PC and ezrin expression in control and ADR-
injected mice; GAPDH was used for normalization. Bottom panel: densitometric quantification of PC and ezrin. d Top panel: immunohistochemical
staining shows PC and ezrin expression in the glomerulus after ADR injury. Mice were sacrificed 14 days after ADR injection, and paraffin-embedded
kidney sections were stained with PC and ezrin antibodies. Bottom panel: computerized morphometric quantification of PC and ezrin staining in the
glomeruli of control and ADR mice. Scale bar= 50 μm; n= 6/group; *P < 0.05 vs. control mice; **P < 0.01 vs. control mice
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SGK3-mediated PC and ezrin protein expression was
involved in PAN-mediated podocyte damage
We recently reported that SGK3 was involved in the
ADR-induced nephritic mouse model and in the
PAN-induced podocyte damage cell model4. However,
it remains unclear whether SGK3 participates in the
regulation of PC and ezrin protein expression. In cultured
mouse podocytes transfected with an eukaryotic expres-
sion vector encoding the constitutively inactivated
K191M mutant of SGK3 (SGK3-K191M), PC mRNA
expression was significantly reduced as compared to
control cells, but ezrin mRNA expression was unaffec-
ted (Fig. 4a). The protein expression levels of PC and
ezrin in the SGK3-K191M-transfected mouse podocytes
Fig. 2 PAN inhibited PC and ezrin protein expression and downregulated PC/ezrin interaction in cultured mouse podocytes. Immortalized
mouse podocytes were exposed to 50 µg/ml PAN for 24 h. a MTT assay was used to measure cell viability after PAN treatment for 24 h. b Top
panel: Immunoblot analysis for desmin expression; GAPDH was used for normalization. Bottom panel: Quantification of desmin by densitometry.
c Immunofluorescence staining showed F-actin rearrangement in PAN-treated podocytes. Scale bar= 25 μm. d After PAN treatment, PC and ezrin
mRNA expression levels were detected with qRT-PCR. e Upper panel: immunoblot analysis of PC and ezrin protein expression. Bottom panel:
densitometric quantification of PC and ezrin. Data are means ± SEs of three independent experiments. *P < 0.05 vs. the control group; **P < 0.01 vs.
the control group. f Confocal immunofluorescence images show PC and ezrin staining in cultured podocytes after treatment with PAN. Scale bar=
25 μm. g After PAN treatment, whole-cell lysates (WCLs) were precipitated with an anti-ezrin antibody. The immunoprecipitates were analyzed with
a western blot using anti-ezrin and anti-PC antibodies. PC and ezrin protein expression in WCLs was analyzed with an immunoblot
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were significantly lower than the PC and ezrin
expression levels in the scramble plasmid-transfected
mouse podocytes (Fig. 4b). This suggested that SGK3
might be involved in the regulation of PC and ezrin
expression.
To further investigate the involvement of SGK3 in the
downregulation of PC and ezrin after PAN-mediated
podocyte injury, cultured mouse podocytes were trans-
fected with the constitutively activated S486D mutant
of SGK3 (SGK3-S486D) or scramble plasmid for 48 h
and treated with PAN for the last 24 h of transfection.
We found that PC and ezrin expression levels were sig-
nificantly lower in the PAN+/S486D− transfected mouse
podocytes, as compared to the PAN−/S486D−-transfected
mouse podocytes. Notably, the expression levels of PC
and ezrin in the PAN+/S486D+-transfected mouse
podocytes were almost equivalent to those in the PAN−/
S486D−-transfected podocytes, indicating that the
increased activation of SGK3 mostly reversed the PAN-
induced downregulation of PC and ezrin. In addition,
PC expression did not differ significantly between the
PAN+/S486D+- and the PAN−/S486D+-transfected
mouse podocytes, suggesting that PAN treatment did not
further downregulate PC protein expression in mouse
podocytes transfected with constitutively activated SGK3
(Fig. 4c).
To study the role of SGK3 in the PC/ezrin complex,
mouse podocytes were transfected with either the
SGK3-K191M or the SGK3-S486D plasmid in vitro. PC
and ezrin binding was then measured with Co-IP assays.
We found that, compared with untransfected mouse
podocytes, the interaction between PC and ezrin
decreased in mouse podocytes transfected with SGK3-
K191M but increased significantly in mouse podocytes
transfected with SGK3-S486D (Fig. 4d). Therefore,
ourresults indicated that SGK3 not only alleviated the
PAN-induced downregulation of PC and ezrin but also
maintained PC/ezrin complex stability.
SGK3 triggered ubiquitin-mediated degradation of PC
and ezrin in cultured mouse podocytes
To explore how SGK3 affected the protein expression
of PC and ezrin, the SGK3-K191M plasmid was trans-
fected into mouse podocytes to decrease SGK3 activity.
The proteasome inhibitor MG132 was added for the
last 8 h of transfection to inhibit protein degradation.
The downregulation of PC and ezrin in SGK3-K191M-
transfected mouse podocytes was mostly reversed by
Fig. 3 PAN enhanced the ubiquitin-mediated degradation of PC and ezrin in cultured mouse podocytes. a After treatment with PAN, mouse
podocytes were either untreated or treated with 10 µM MG132 for the last 8 h of transfection. Left panel: immunoblot analysis showing PC and ezrin
expression. GAPDH was used for normalization. Right panel: densitometric quantification of PC and ezrin. Data are means ± SEs of three independent
experiments. *P < 0.05 vs. the PAN−/MG132− cells, **P < 0.01 vs. the PAN−/MG132− cells. #P < 0.05 vs. the PAN+/MG132− cells. b Mouse podocytes
were transfected with a Ub-FLAG plasmid for 48 h and treated with PAN for the last 24 h of transfection. The proteasome inhibitor MG132 was added
to the mouse podocytes for the last 8 h of transfection to prevent protein degradation. WCLs were precipitated with anti-FLAG antibodies, and the
immunoprecipitates were immunoblotted with anti-PC antibodies. PC and ezrin expression was measured in WCLs after PAN treatment using
immunoblotting. c Mouse podocytes were treated with PAN for 24 h and with MG132 for the last 8 h of PAN treatment. WCLs were precipitated with
anti-ezrin antibodies, and the immunoprecipitates were immunoblotted with anti-ezrin and anti-ubiquitin antibodies
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MG132 (Fig. 5a), indicating that SGK3 may regulate PC
and ezrin expression through the proteasome pathway.
Consistent with this, PC and ezrin ubiquitination levels
were significantly higher in the SGK3-K191M-transfected
mouse podocytes as compared to control mouse podo-
cytes (Fig. 5b, c). These results suggested that, in the
absence of SGK3 activity, PC and ezrin degradation is
stimulated through the ubiquitin–proteasome degrada-
tion pathway.
The SGK3/Nedd4-2 signaling pathway played a role in
podocyte injury in vivo and in vitro
To investigate why the lack of SGK3 activity increased
PC and ezrin ubiquitination, we tested whether the SGK3
target protein Nedd4-2, a common E3 ubiquitin ligase,
was involved in podocyte damage in vivo or in vitro.
We first confirmed that SGK3 regulated Nedd4-2 phos-
phorylation (Fig. 6a). That is, the p-Nedd4-2/Nedd4-2
ratio decreased significantly in the SGK3-K191M-
A B
C
PAN
S486D
- +       - +     
- - +       +     
PAN
S486D
- +       - +     
- - +       +     
D
IP?Ezrin
IB?Ezrin
-80KD
-170KDIP?Ezrin
IB?PC
WB: GAPDH -36KD
WB:SGK3 -61KD
- - +     
- +       -K191M
S486D
PC -120KD
- - +     +
- +      - +     PAN
S486D
SGK3 -61KD
GAPDH -36KD
-80KDEzrin
GAPDH -36KD
GAPDH -36KD
DK08-nirzE
SGK3 -61KD
Con K191M
-170KDPC
0
Fig. 4 SGK3-triggered PC and ezrin protein expression was involved in PAN-induced podocyte damage. a The scramble (control) or SGK3-
K191M plasmid were transiently transfected into cultured mouse podocytes for 48 h. qRT-PCR was used to detect the mRNA expression levels of PC
and ezrin. b Upper panel: immunoblot of PC and ezrin expression; GAPDH was used for normalization. Bottom panel: densitometric quantification of
PC and ezrin. Data are means ± SEs of three independent experiments. *P < 0.05 vs. the control group, **P < 0.01 vs. the control group. c The scramble
(control) or SGK3-S486D plasmid were transiently transfected into cultured mouse podocytes for 48 h. The podocytes were exposed to 50 µg/ml PAN
for the last 24 h of transfection. Top panel: immunoblot showing expression of SGK3, PC, and ezrin; GAPDH was used for normalization. Bottom panel:
densitometric quantification of SGK3, PC, and ezrin. Data are means ± SEs of three independent experiments. **P < 0.01 vs. the PAN−/S486D− group;
##P < 0.01 vs. the PAN+/S486D− group. d Mouse podocytes were transfected with the scramble (control) plasmid, SGK3-K191M, or SGK3-S486D
plasmid in vitro. WCLs were precipitated with anti-ezrin antibody, and the immunoprecipitates were immunoblotted with anti-ezrin and anti-PC
antibodies. SGK3 expression was measured in WCL immunoblots after SGK3-K191M or SGK3-S486D transfection
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transfected mouse podocytes compared to the scramble
plasmid-transfected mouse podocytes. We next verified
the involvement of Nedd4-2 in podocyte damage both
in vivo and in vitro. The p-Nedd4-2/Nedd4-2 ratio
decreased obviously in both the ADR nephritic mouse
model and the PAN-induced podocyte injury cell model,
implying a significant increase in Nedd4-2 activity and
confirming the involvement of Nedd4-2 in podocyte
damage (Fig. 6b, c). Finally, we investigated the role of the
SGK3/Nedd4-2 signaling pathway in PAN-induced
podocyte damage in vitro. The activity of Nedd4-2 was
lower in PAN−/S486D+-transfected mouse podocytes
than in PAN−/S486D−-transfected mouse podocytes
(Fig. 6c). However, SGK3 activation completely reversed
the PAN-induced decrease in the p-Nedd4-2/Nedd4-2
ratio (Fig. 6c). Therefore, our results strongly suggested
that the SGK3/Nedd4-2 signaling pathway was involved in
podocyte damage both in vivo and in vitro.
Nedd4-2 modulated ezrin protein expression, but not PC
protein expression, through the ubiquitin–proteasome
pathway in cultured mouse podocytes
To investigate whether the SGK3 target protein Nedd4-
2 was involved in PC and ezrin expression and ubiquiti-
nation, we examined the effect of Nedd4-2 activation on
PC and ezrin protein expression. Mouse podocytes were
transfected with the wild-type (WT) Nedd4-2 plasmid or
scramble plasmid for 48 h. Transfected mouse podocytes
A
B
K191M
MG132
- +     - +     
- - +     +     
K191M
MG132
- +    - +     
- - +    +     
K191M
MG132
- +     - +     
- - +     +     
C
-80KD
IP?Ezrin
IB?Ezrin
-170KDIP?FLAG-PC
IB?PC
-36KDWB:GAPDH
-61KDWB:SGK3
-250KD
-170KD
Con K191M
IP?FLAG-PC
IB?UB Ub
Con K191M
-80KD
IP?Ezrin
IB?UB
PC -170KD
GAPDH -36KD
SGK3 -61KD
Ezrin -80KD
GAPDH -36KD
- - +     +
- +      - +     K191M
MG132
Fig. 5 SGK3 inactivation promotes the ubiquitin-mediated degradation of PC and ezrin in cultured mouse podocytes. Mouse podocytes
were transfected with the scramble (control) or SGK3-K191M plasmid. After 40 h of transfection, cells were either untreated or treated with MG132 for
additional 8 h. a Left panel: immunoblot showing SGK3, PC, and ezrin expression; GAPDH was used for normalization. Right panel: densitometric
quantification of SGK3, PC, and ezrin. Data are means ± SEs of three independent experiments. *P < 0.05 vs. the K191M−/MG132−-transfected group.
#P < 0.05 vs. the K191M+/MG132−-transfected group. b PC-FLAG-transfected mouse podocytes were either mock co-transfected or co-transfected
with the SGK3-K191M plasmid and then treated with MG132 for the last 8 h of transfection. Upper panel: WCLs were precipitated with the anti-FLAG
antibody, and the immunoprecipitates were blotted with anti-PC and anti-Ub antibodies. WCL immunoblots were used to measure SGK3 expression
after SGK3-K191M transfection. Bottom panel: The level of ubiquitinated ezrin was normalized to the immunoprecipitated PC. c Mouse podocytes
were transfected with scramble (control) or SGK3-K191M plasmid for 48 h and then treated with MG132 for the last 8 h of transfection. Upper panel:
WCLs were precipitated with anti-ezrin antibody, and western blots with anti-ezrin and anti-Ub antibodies were performed after the
immunoprecipitates. Bottom panel: The level of ubiquitinated ezrin was normalized to the immunoprecipitated ezrin. Data are means ± SEs of three
independent experiments. *P < 0.05 vs. control group
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were then untreated or treated with MG132 for the last 8
h of transfection. Ezrin protein expression was sig-
nificantly lower in the Nedd4-2+/MG132−-transfected
mouse podocytes than in the Nedd4-2−/MG132−-trans-
fected mouse podocytes, while PC protein expression
remained unchanged (Fig. 7a). Moreover, after adminis-
tration of MG132, the decreased expression of ezrin in the
Nedd4-2+/MG132− group was partially reversed in the
Nedd4-2+/MG132+ group (Fig. 7a). Ezrin ubiquitination
was significantly higher in WT Nedd4-2-transfected
mouse podocytes than in the scramble plasmid-
transfected mouse podocytes (Fig. 7b). These results
indicated that Nedd4-2 downregulated ezrin, but not PC,
through the ubiquitin–proteasome degradation pathway.
All three Nedd4-2 short hairpin RNAs (shRNAs; #1, #2,
and #3), as well as the Nedd4-2 control shRNA, were used
to infect mouse podocytes. Although two Nedd4-2
shRNAs (#2 and #3) visibly inhibited Nedd4-2, the
shRNA (#2) had the highest Nedd4-2 inhibition efficiency
and was thus selected for subsequent infections (data not
shown). Silencing Nedd4-2 increased ezrin protein
expression and increased ezrin ubiquitination (Fig. 7c, d).
Together, our results strongly suggested that Nedd4-2
downregulated ezrin protein expression by increasing
ezrin ubiquitination.
SGK3-mediated Nedd4-2 activity affected the interaction
between Nedd4-2 and ezrin
As our results indicated that Nedd4-2 induced ezrin
ubiquitination, we next tested whether SGK3-mediated
Nedd4-2 activity affected the interaction between Nedd4-
2 and ezrin. To test this, we performed Co-IP studies on
HEK293T cells. HEK293T cells were transfected with WT
Nedd4-2, with or without one of the plasmids SGK3-
K191M and SGK3-S486D. Transfection with SGK3-
K191M led to increased Nedd4-2 activity and decreased
C
PAN
S486D
- +     - +     
- - +     +     
BA
Con ADR
DK021-2-4ddeN
p-Nedd4-2 -120KD
DK63-HDPAG
Nedd4-2 -120KD
-36KDGAPDH
Con K191M
p-Nedd4-2 -120KD
- - +     +
- +      - +     PAN
S486D
GAPDH -36KD
-120KDp-Nedd4-2
-120KDNedd4-2
Fig. 6 The SGK3/Nedd4-2 signaling pathway was involved in podocyte damage both in vivo and in vitro. a Mouse podocytes were
transfected with either the scramble (control) or the SGK3-K191M plasmid for 48 h. Upper panel: immunoblot showing p-Nedd4-2 and Nedd4-2
expression; GAPDH was used for normalization. Bottom panel: densitometric quantification of the p-Nedd4-2/Nedd4-2 ratio. Data are means ± SEs of
three independent experiments. **P < 0.01 vs. the control group. b Upper panel: immunoblot showing p-Nedd4-2 and Nedd4-2 expression in control
and ADR-injected mice; GAPDH was used for normalization. Bottom panel: Densitometric quantification of the p-Nedd4-2/Nedd4-2 ratio (6 samples/
group). **P < 0.01 vs. the control mice. c The scramble or SGK3-S486D plasmid were transiently transfected into cultured mouse podocytes.
Podocytes were treated with PAN for the last 24 h of transfection. Left panel: immunoblot showing p-Nedd4-2 and Nedd4-2 expression; GAPDH was
used for normalization. Right panel: densitometric quantification of the p-Nedd4-2/Nedd4-2 ratio. Data are means ± SEs of three independent
experiments. **P < 0.01 vs. PAN−/S486D−-transfected group; ##P < 0.01 vs. the PAN+/S486D−-transfected group
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ezrin expression, while transfection with SGK3-S486D led
to decreased Nedd4-2 activity (Fig. 8a). As ezrin harbors
PY, the motif targeted by Nedd4-2, it was unsurprising
that Nedd4-2 and ezrin interacted in HEK293T cells
under basic conditions (Fig. 8b). After transfection with
SGK3-K191M and WT Nedd4-2, Nedd4-2 and ezrin
interaction increased in HEK293T cells, while Nedd4-2
and ezrin interaction decreased after transfection with
SGK3-S486D and WT Nedd4-2 (Fig. 8b). Therefore,
increased Nedd4-2 activity mediated by the inactivation of
SGK3 also increased the interaction between Nedd4-2
and ezrin.
C
BA
Nedd4-2 -120KD
-80KDEzrin
PC -170KD
GAPDH -36KD
- - +     +
- +      - +     Nedd4-2
MG132
Nedd4-2
MG132
- +      - +     
- - +      +     
Nedd4-2
MG132
- +      - +     
- - +      +     
D
-80KDIP?Ezrin
IB?Ezrin
ConNedd4-2
Ub
-80KD
IP?Ezrin
IB?UB
WB:GAPDH -36KD
WB:Nedd4-2 -120KD
Ub
ConNedd4-2i
-80KD
IP?Ezrin
IB?UB
-80KDIP?EzrinIB?Ezrin
WB:GAPDH -36KD
WB:Nedd4-2 -120KD
Con Nedd4-2i
DK021-2-4ddeN
GAPDH -36KD
-80KDEzrin
Fig. 7 Nedd4-2 modulated ezrin ubiquitination but not PC ubiquitination. Mouse podocytes were transfected with either the pcDNA3 (Con) or
the WT Nedd4-2 plasmid for 48 h. Cells were either untreated or treated with MG132 for the last 8 h of transfection. a Upper panel: immunoblot
showing Nedd4-2, PC, and ezrin expression; GAPDH was used for normalization. Bottom panel: densitometric quantification of PC and ezrin. *P < 0.05
vs. Nedd4-2-/MG132-group. bWCLs were precipitated with the anti-ezrin antibody, and the immunoprecipitates were immunoblotted with anti-ezrin
and anti-Ub antibodies. Upper panel: immunoblots were used to measure Nedd4-2 expression in WCLs after transfection with the WT Nedd4-2
plasmid. Bottom panel: The level of ubiquitinated ezrin was normalized to the immunoprecipitated ezrin. Data are means ± SEs of three independent
experiments. *P < 0.05 vs. control group. c Mouse podocytes were infected with scramble (control) or Nedd4-2-specific shRNAs for 72 h. Top panel:
immunoblot showing Nedd4-2 and ezrin expression; GAPDH was used for normalization. Bottom panel: densitometric quantification of Nedd4-2 and
ezrin. Data are means ± SEs of three independent experiments; for each sample, three wells were treated. **P < 0.01 vs. the control group. d Mouse
podocytes were transfected with recombinant lentiviral Nedd4-2-eGFP shRNA or scramble (control) lentiviral shRNA. WCLs were precipitated with the
anti-ezrin antibody, and the immunoprecipitates were immunoblotted with anti-ezrin and anti-Ub antibodies. Nedd4-2 expression in WCLs was
measured with immunoblot assays after Nedd4-2 shRNA transfection
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SGK3 and the SGK3/Nedd4-2 signaling pathway are
involved in the regulation of the ezrin/PC interaction
To explore whether SGK3 and the SGK3/Nedd4-2 sig-
naling pathway regulated the stability of the PC/ezrin
complex, we performed Co-IP assays in HEK293T cells.
To do this, we first transfected the SGK3-K191M plasmid
into HEK293T cells expressing PC-FLAG. We detected
three bands in the PC-FLAG-transfected HEK293 cells.
PC, but not ezrin, protein expression was downregulated
in the transfected HEK293T cells, as compared to control
cells (Fig. 9a). As Nedd4-2 is not expressed in HEK293
cells32,33, these results suggested that SGK3-mediated
ezrin expression depended on Nedd4-2 but that SGK3-
mediated PC expression did not. Moreover, the inactiva-
tion of SGK3 decreased PC expression, directly reducing
the interaction between PC and ezrin (Fig. 9a).
We next transfected the HEK293T cells expressing PC-
FLAG with the WT Nedd4-2 plasmid. Ezrin protein
expression was downregulated after WT Nedd4-2 plasmid
transfection; PC protein expression remained constant
(Fig. 9b). The interaction between PC and ezrin in the
cells transfected with WT Nedd4-2 was significantly lower
than that in the control cells. This indicated that the
activation of Nedd4-2 decreased ezrin expression, but not
PC expression, contributing to the decreased interaction
between PC and ezrin. In addition, we found that ezrin
co-precipitated with PC in the PC-FLAG-transfected
HEK293T cells, indicating that exogenously expressed
PC interacts with endogenous ezrin in HEK293T cells,
and suggesting that this interaction does not require the
co-expression of additional podocyte-specific proteins
(Fig. 9a, b).
Finally, we examined the role of the SGK3/Nedd4-
2 signaling pathway with respect to the PC/ezrin inter-
action. To do this, HEK293T cells expressing PC-FLAG
were co-transfected with WT Nedd4-2 and either the
SGK3-K191M or the SGK3-S486 plasmid. The PC/ezrin
interaction was reduced in cells transfected with SGK3-
K191M as compared to control cells, while the PC/ezrin
interaction increased in cells transfected with SGK3-
S486D as compared to control cells (Fig. 9c). As SGK3
targets Nedd4-2, our results suggested that SGK3 and the
SGK3/Nedd4-2 signaling pathway were both involved in
regulating the stability of the PC/ezrin complex.
Discussion
SGK3, an important downstream target protein of
phosphatidylinositol-3-kinase, is involved in the regula-
tion of substrate transport7, as well as cell growth, survi-
val, and proliferation34,35. Previously, we showed that
SGK3 deficiency leads to decreased podocin expression
and reduced podocyte viability4. However, the signaling
mechanisms involved in SGK3-triggered podocyte func-
tion are not well known. Here we found that PC and ezrin
Nedd4-2 - +      +      +     
S486D - - - +     
K191M - - +      -
Nedd4-2 - +      +      +     
S486D - - - +     
K191M - - +      -
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Nedd4-2 - +      +      +     
S486D - - - +     
K191M - - +      -
A
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p-Nedd4-2 -120KD
Nedd4-2 -120KD
GAPDH -36KD
Ezrin -80KD
Nedd4-2 - +      +      +     
S486D - - - +     
K191M - - +      -
-80KDIP?Ezrin
IB?Ezrin
-120KDIP?Ezrin
IB?Nedd4-2
WB: SGK3 -61KD
WB:Nedd4-2 -120KD
WB:GAPDH -36KD
Fig. 8 SGK3-mediated Nedd4-2 phosphorylation affected the interaction between Nedd4-2 and ezrin. a Upper panel: HEK293T cells were
transfected with the indicated plasmids. Immunoblot analysis of SGK3, P-Nedd4-2, Nedd4-2, and ezrin expression; GAPDH was used for normalization.
Bottom panel: densitometric quantification of the P-Nedd4-2/Nedd4-2 ratio and ezrin. Data are means ± SEs of three independent experiments. #P <
0.05 vs. cells transfected with Nedd4-2+/K191M−/S486D−. b WCLs were precipitated with the anti-ezrin antibody, and the immunoprecipitates were
blotted with anti-ezrin and anti-Nedd4-2 antibodies. SGK3 and Nedd4-2 expression levels in the WCLs were measured with immunoblot assays
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Fig. 9 SGK3 and the SGK3/Nedd4-2 signaling pathway were involved in the regulation of PC/ezrin interaction. a HEK293T cells were mock
transfected or transfected with the SGK3-K191M plasmid for 24 h. WCLs were precipitated with anti-FLAG antibodies and then blotted with anti-FLAG
and anti-ezrin antibodies. FLAG, SGK3, and ezrin expression levels were measured in the WCLs with immunoblot assays. b pc-FLAG-transfected
HEK293T cells were mock co-transfected or co-transfected with the WT Nedd4-2 plasmid for 24 h. Immunoblots of the WCLs were precipitated with
anti-FLAG antibodies and blotted with anti-FLAG and anti-ezrin antibodies. FLAG, Nedd4-2, and ezrin expression levels in the WCLs were measured
with immunoblot assays. c HEK293T cells were transfected with the indicated plasmids for 24 h. Immunoblots of the WCLs were precipitated with the
anti-FLAG antibody, and blotted with anti-FLAG and anti-ezrin antibodies. FLAG, SGK3, Nedd4-2, and ezrin expression levels in the WCLs were
measured with immunoblot assays
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protein expression levels were reduced after podocyte
damage, both in vivo and in vitro. We demonstrated that
both PAN treatment and SGK3 inactivation resulted in
increased PC and ezrin ubiquitination and that SGK3
activation partially reversed PAN-induced decreases in PC
and ezrin protein expression. Moreover, the enhancement
of Nedd4-2 activity via SGK3 inactivation increased ezrin
ubiquitination but not PC ubiquitination. Our results
suggested that SGK3 and the SGK3/Nedd4-2 signaling
pathway helped to maintain the stability of the PC/ezrin
complex in vitro.
One intriguing finding of our study was that
decreased PC and ezrin protein expression was not
caused by reduced PC and ezrin mRNA transcription
after PAN-induced podocyte damage. Rather, this
decreased protein expression primarily resulted from
the increased PC and ezrin protein degradation induced
via the ubiquitinproteasome pathway. Ezrin, a plasma
membrane–cytoskeleton linker protein, mainly reg-
ulates cell adhesion and morphogenesis36. Previous
studies have shown that ezrin activity and/or expression
decreases in animal models of glomerular disease28,37
and in nephropathic patients29,37. Consistent with these
studies, we found that ezrin was downregulated after
podocyte damage both in vivo and in vitro, suggesting
that decreased ezrin expression may be a marker
for podocyte damage. PC is the most highly sialylated
glycoprotein in podocytes13,23. Several studies have
reported the downregulation of PC in ADR models38–40
and upregulation of PC mRNA expression in mouse
podocytes after PAN-induced podocyte damage41,42.
Both of these findings were consistent with our results.
Incongruent with our results, some studies have
shown that PC protein expression increased in mouse
podocytes with PAN-induced podocyte damage41,42,
but this discrepancy was probably due to differences
in experimental methods (e.g., PAN treatment period
or concentration).
We previously implicated SGK3 in the mediation of
PAN-induced podocyte damage4, but the mechanisms
underlying this mediation remained unclear. Here we
linked SGK3 activation to PC and ezrin protein expres-
sion after podocyte damage, both in vivo and in vitro. The
downregulation of SGK3 not only suppressed PC mRNA
transcription but also inhibited PC and ezrin protein
expression. In addition, SGK3 activation mostly reversed
the PAN-induced inhibition of PC and ezrin protein
expression. Our results therefore convincingly indicated
that SGK3 affected PAN-induced podocyte damage by
triggering PC and ezrin protein expression. It should
be noted that SGK3 inactivation decreased PC mRNA
expression, while PAN treatment increased PC mRNA
expression, suggesting that PAN-induced podocyte
damage did not depend solely on SGK3 activity.
The mechanisms underlying this contradiction (i.e., that
PAN treatment led both to SGK3 inactivation and to
increased PC mRNA expression) are still unclear and
merit further investigation.
We have shown here, for the first time, that SGK3
activation triggers the ubiquitin-mediated degradation of
PC and ezrin. This novel result provides insight into
the pathomechanism of SGK3 in podocytes. It is well
known that PC and ezrin are regulated by a variety of
factors, including phosphorylation, binding partners28,
and ubiquitination43. A recent study showed that ezrin
was ubiquitinated by WWP1, a HECT ubiquitin ligase26
that mediates the alteration of ezrin function, but does
not degrade ezrin44. However, the ubiquitination of PC
has not previously been reported. Herein we found that
SGK3 inactivation led to PC and ezrin protein degrada-
tion, primarily via the proteasome pathway. Interestingly,
we found that the SGK3-targeted protein Nedd4-2
mediated ezrin ubiquitination, but not PC ubiquitina-
tion, indicating that SGK3 modulates PC and ezrin
degradation through different regulatory mechanisms.
This result was consistent with the known protein
structures, in that there is a PY motif in ezrin but not
in PC. The PY motif can be bound, and therefore regu-
lated, by Nedd4-2. Consistent with this, SGK3 phos-
phorylates Nedd4-2 and regulates the binding of Nedd4-2
with its target protein, ezrin (Fig. 8). It should be stressed
that the molecular details of SGK3-mediated PC ubiqui-
tination remain obscure. In addition, unlike WWP1-
mediated ezrin ubiquitination, Nedd4-2-mediated ezrin
ubiquitination decreased ezrin protein expression.
Several studies have shown that structural and/or
functional defects in either PC or the associated cytos-
keletal linker proteins may result in glomerular dis-
orders17. Disruption of the PC/ezrin interaction in
glomerular epithelial cells is associated with the depho-
sphorylation of ezrin, the neutralization of the negative
PC surface charge17,24, and the decreased protein
expression of either PC or ezrin24. Here we found that the
deceased SGK3 activity resulted in decreased PC and
ezrin protein expression, consistent with the disrupted
binding of PC and ezrin in SGK3-inactivated mouse
podocytes and HEK293T cells. SGK3 downregulation led
to decreased PC mRNA expression and to increased
PC and ezrin protein degradation. Together, these
effects might disrupt the PC/ezrin interaction. Notably,
Nedd4-2 activity did not influence PC expression. This
indicated that the decreased stability of the PC/ezrin
complex induced by the decrease in SGK3 activity was not
completely dependent on the SGK3/Nedd4-2 signaling
pathway. Several studies have focused on the role of
AKT in the kidney8–10. AKT is highly structurally and
functionally homologous with SGK311. AKT2 maintains
podocyte viability and function via the AKT/mammalian
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target of rapamycin or the AKT/GSK3β pathways10,45.
SGK3 might regulate PC expression through the similar
AKT pathway, and indeed, other pathways underlying
podocyte dysfunction might be induced by a decrease in
SGK3 activity.
In summary, SGK3 inactivation played an important
role in the regulation of PC and ezrin expression. Here we
demonstrated that SGK3 inactivation downregulated PC
mRNA and upregulated the ubiquitin-mediated degra-
dation of PC and ezrin, thereby inhibiting the protein
expression of PC and ezrin. These changes destabilized
the PC/ezrin complex. Moreover, SGK3-triggered Nedd4-
2 activity degraded ezrin rather than PC (Fig. 10). Col-
lectively, our results suggested that the regulation of
SGK3 and the SGK3/Nedd4-2 signaling pathway deter-
mines the stability of the podocyte PC/ezrin complex.
Methods and materials
Reagents and antibodies
Polyclonal rabbit anti-SGK3, anti-Nedd4-2 and anti-
phospho-Nedd4-2 (Ser342) antibodies were purchased
from Cell Signaling Technology, Inc. (Beverly, MA, USA).
Polyclonal rabbit anti-ezrin was purchased from Abcam
(Cambridge, MA, USA). Polyclonal goat anti-PC antibody
was purchased from Research & Diagnostics Systems, Inc.
(Minneapolis, MN, USA). Polyclonal rabbit anti-Desmin
(I-448) was purchased from Bioworld Technology, Co.
Ltd. (Nanjing, China). Monoclonal mouse anti-GAPDH
antibody; polyclonal rabbit anti-flag tag antibody; and
horseradish peroxide-conjugated anti-rabbit, anti-mouse,
and anti-goat secondary antibodies were purchased from
Proteintech (Wuhan, China). Monoclonal mouse anti-
ubiquitin antibody was purchased from Covance Inc. (UT,
USA). The pcDNA3/mNedd4-2, pMO/mSGK3-K191M
(SGK3-K191M), and pMO/mSGK3-S486D (SGK3-
S486D) plasmids were constructed as previously descri-
bed4. The PC-Myc-DDK plasmid (Flag-epitope at
N−terminal of mouse PC) was purchased from Origene
Technologies, Inc. (Rockville, MD, USA). The plasmid of
the mouse Flag-tagged WT Ub was provided by Dr.
Qiuhong Duan (Department of Biochemistry and Mole-
cular Biology, Tongji Medical College, Huazhong Uni-
versity of Science & Technology, Wuhan, China). Three
recombinant lentiviruses against Nedd4-2 were designed
and generated by Genechem (Shanghai, China). PAN was
purchased from Sigma Chemical (St Louis, MO, USA).
MG132 was purchased from Selleck (Shanghai, China). A/
G plus agarose for immunoprecipitation (IP) assay was
purchased from Beyotime Biotechnology (Shanghai,
China). Phosphatase inhibitor mixture and proteinase
inhibitor cocktail were purchased from Roche Applied
Science (Indianapolis, IN).
ADR nephritis mouse model
All experiments were performed in accordance with
the National Institutes of Health guidelines for the
use and care of experimental animals and were approved
by the Animal Care and Use Committee of Tongji Med-
ical College. The generation and characters of ADR-
induced nephrosis model were previously described4.
Briefly, male mice (8-week-old), body weight 20–25 g,
were treated with a single dose of 10.5 mg/kg ADR
(Sigma, USA, D1515) by tail vein injection (ADR group,
n= 6). The mice in the control group were administered
with an equivalent volume of phosphate-buffered saline
(PBS) (control group, n= 6). On day 14, the mice
were sacrificed under anesthesia and both blood samples
and kidneys were collected. The harvested kidneys were
collected for western blotting and immunohistochemical
analysis.
Histochemistry and immunohistochemistry
PAS staining and immunohistochemistry studies pro-
ceeded and analyzed essentially as previously described4.
In short, paraffin-embedded mouse kidney sections
(5-μm thickness) for PAS and immunohistochemical
staining were performed using routine protocol. Sections
were stained with PAS reagent by standard procedure.
Immunohistochemistry staining was performed using
routine protocol. The slides were incubated with rabbit
polyclonal anti-ezrin antibody and goat anti-PC antibody
overnight at 4 °C, followed by incubation with poly-
peroxidase anti-rabbit and anti-goat IgG secondary anti-
bodies for 30min at room temperature. Staining was
then performed using a DAB Kit. Histological
SGK3 acvity ↓
Nedd4-2 acvity ↑ PC mRNA ↓ PC ubiquinaon ↑
Ezrin ubiquinaon ↑
PC expression ↓Ezrin expression ↓
PC/Ezrin binding ↓
Fig. 10 Schematic diagram showed how SGK3 stabilizes the PC/
ezrin complex. SGK3 inactivation upregulated the activity of its target
protein Nedd4-2, which resulted in increased ezrin ubiquitination,
downregulated ezrin protein expression, and reduced PC and ezrin
interaction. In addition, downregulated SGK3 activity also reduced PC
mRNA and protein expression, thus affecting the stability of the PC/
ezrin complex
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examination was performed via light microscopy. Positive
expression for PC and ezrin were semi-quantitative using
the Image Pro Plus software.
Urine and serum biochemistry
Blood urea nitrogen and urinary and serum creatinine
levels were determined by using the respective kits
(NINGBO ELEJECH Biological Technology Co., LTD,
Zhejiang, China), according to the manufacturer’s proto-
cols. Urinary albumin was standardized to urinary crea-
tinine and expressed as mg/mg Ucr.
Cell culture, transfection, and recombinant lentivirus
infection
The conditional immortalized mouse podocytes were
handled as described earlier4. Briefly, cells were main-
tained in RPMI 1640 medium (HyClone, USA) supple-
mented with 10% (v/v) fetal bovine serum (GIBCO,
Thermo Fisher Scientific Inc. USA), 100 U/ml penicillin,
and 100 µg /ml streptomycin. To propagate podocytes,
cells were cultivated on type I collagen at 33 °C under 5%
CO2 and 95% air in culture medium supplemented with
10 U/ml recombinant interferon-γ (IFN-γ). To induce
differentiation, podocytes were transferred at 37 °C in
IFN-γ-free medium. Mouse podocytes between passages
9 and 20 were used in all experiments. HEK293T cell
cultures were maintained at 37 °C in Dulbecco’s modified
Eagle’s medium (HyClone, USA), supplemented with 10%
fetal bovine serum, 100 U/ml penicillin, and 100 μg/ml
streptomycin. Mouse podocytes and HEK293T cells were
transiently transfected with various plasmids and respec-
tive scramble plasmids using Lipofectamine 2000 reagent
(Invitrogen, Carlsbad, CA) according to the manu-
facturer’s protocol for adherent cells. Cells were analyzed
24–48 h post transfection. Mouse podocytes were infected
with scramble or Nedd4-2-specific lentiviruses. Seventy-
two hours after shRNA infection, western blotting was
used to evaluate the suppression of Nedd4-2 expression
in different cell groups.
Cell viability assay
Cell viability was assessed by an MTT assay. Briefly,
mouse podocytes were seeded into 96-well plates at a
density of 2 × 103/well followed by treatment with or
without PAN administration for 24 h. In all, 10 μl of 5 mg/
ml MTT solution in PBS was added without removal of
culture medium followed by incubation at 37 °C for 4 h.
The medium was removed and 100 μl of dimethyl sulf-
oxide was added to dissolve the formazan crystals for
about 15 min by a shaker. Absorbance of each well was
measured by a microplate reader (BioTek, Winooski, VT,
USA) at 570-nm wavelength, followed by calculating
the mean value. All data were determined from three
independent cultures.
Immunofluorescence staining and and confocal
microscopy
Mouse podocytes grown on glass coverslips were
fixed with 4% paraformaldehyde for 30min and permea-
bilized with 0.1% Triton X-100 in PBS for 5 min. After
blocking with 10% donkey serum for 30min, the slides
were immunostained with primary antibodies against PC
and ezrin. The slides were then stained with IFKine green-
conjugated donkey anti-goat antibody (#A24231, Abb-
kine) and Alexa Fluor 594-conjugated donkey anti-rabbit
antibody (127803, Jackson). Cells were costained with 4,6-
diamidino-2-phenylindole (blue). For F-actin staining,
slides was stained with rhodamine–phalloidin (Invitrogen,
Carlsbad, CA) for 20 min at room temperature. Images
were acquired using a Leica TCS-SL confocal microscope.
Western blot analysis
Protein expression was analyzed by western blot ana-
lysis as described previously4. In brief, protein extracts
from the kidneys as well as whole-cell protein from
stable cell lines were used. Equal amounts of proteins
were loaded on sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) gels for separation and
transferred onto polyvinylidene difluoride membrane
(Millipore Corp., Bedford, MA). Membranes were then
blocked for 1 h at room temperature using 5% skim milk
and 0.1% Tween 20 in Tris-buffered saline. The immu-
noblot was then performed overnight at 4 °C using
appropriate primary antibodies. Protein signals were
detected using the corresponding horseradish peroxidase-
conjugated secondary antibody and enhanced chemilu-
minescence (Millipore, Germany). All experiments were
performed in triplicate, and the blots of p-Nedd4-2 and
Nedd4-2 were taken from the same membrane.
Real-time RT-PCR analysis
Total RNA isolation and quantitative RT-PCR (qRT-
PCR) were carried out by a routine procedure. Total RNA
was isolated from incubated cells using TRIzol Reagent
(Invitrogen, Thermo Fisher Scientific Inc. USA) according
to the manufacturer’s instructions. The first-strand cDNA
was carried out using a ReverAid First Strand cDNA
Synthesis Kit (Thermo, Thermo Fisher Scientific Inc.
USA) according to the manufacturer’s protocol. Real-time
RT-PCR was performed on the CFX96 Touch™ Real-Time
PCR Detection System (Bio-rad, Hercules, CA, USA). The
PCR results for each sample were normalized using gly-
ceraldehyde 3-phosphate dehydrogenase (GAPDH)
mRNA as an internal control. The ΔΔCt technique was
used to calculate cDNA content in each sample. Primers
for PC and ezrin were designed based on the GenBank
accession numbers (PC: NM_013723, ezrin: NM_22350).
The sequences of the primer pairs used in RT-PCR are as
follows: mouse PC forward: CTGTAAGCGACCT
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GAACCGT, backward: TGCTGCCACCTTGATGTCTA;
mouse ezrin forward: TCACAGAGGCAGAGAAGA
ATG, backward: TCTCGTTGTGGATGATGTCA; and
mouse GAPDH forward: GTCAAGCTCATTTCCTGG
TATG, backward: CCTCTCTTGCTCAGTGTCCTT. All
experiments were performed in triplicate.
Ubiquitination assay in mouse podocytes
Ubiquitination assays were performed as described32.
Mouse podocytes were treated with 50 μg/ml PAN or
transfected with expression constructs (as shown in the
figures). To inhibit proteasomal degradation, 10 μM
MG132 was added to mouse podocytes 8 h before lysis.
Twenty-four hours after PAN treatment or 48 h after
transfection, cells were washed with PBS and dissociated
in 1 ml dissociation buffer [5% glycerol, 1 mM EDTA,
and 1mM EGTA (pH 8.0)]. Then cells were washed with
10ml PBS and centrifuged at 4 °C, 3000 rpm, for 15min.
Cell pellets were frozen at −70 °C for 2–4 h. Pellets were
then resuspended in 1ml lysis buffer [50 mM HEPES
(pH 7.5), 1 mM EGTA, 150 mM NaCl, 1.5 mM MgCl2,
10% glycerol, 1% TritonX-100, 25 mM sodium fluoride,
40 mM β-glycerolphosphate, 10 mM sodium pyropho-
sphate] containing phenylmethanesulfonylfluoride, cock-
tail, and phosphatase inhibitors. The lysates were
centrifuged at 13,000 rpm (4 °C) for 15min. The super-
natant proteins (about 1.5 mg) were subjected to IP using
the appropriate primary antibody (anti-ezrin antibody,
anti-Flag antibody) and protein A/G agarose beads over-
night at 4 °C. Sample loading buffer 5× was added to the
immunoprecipitates and boiled for 10min. The samples,
centrifuged at 13,000 rpm for 5 min, were separated by
SDS-PAGE for western blot analysis and immunoblotted
with anti-ubiquitin or anti-PC antibody. Scanning densi-
tometry was measured as described above.
Co-IP assays
Mouse podocytes were maintained and administered
with PAN for 24 h or transfected with appropriate
expression constructs for 48 h. HEK293T cells, grown on
10-cm dishes, were transfected with 10 μg of the plasmids
DNA encoding FLAG-tagged PC, mouse Nedd4-2, mouse
SGK3-S486D, mouse SGK3-K191M, and/or empty vector
using Lipofectamine 2000 reagent for 24 h. After treat-
ment and transfection, cells were dissociated in 500 μl IP
lysis buffer (Beyotime Biotechnology, Shanghai, China).
Proteins (about 1.0 mg) were incubated with the appro-
priate primary antibody (anti-ezrin antibody, anti-Flag
antibody) and protein A/G agarose beads. Then the
samples were subjected to western blot analysis.
Statistical analysis
All data are expressed as the mean ± SE. SPSS 13.0
(SPSS, Inc., Chicago, IL) was used for data analysis. A one-
way analysis of variance (ANOVA) or two-tailed Student’s
t test was used to determine statistical significance
between the control and test groups. A one-way ANOVA
with Dunnett’s posttest for >2 groups. A P value of ≤0.05
was considered significant. Analyses were performed
using the Graphpad Instat software (San Diego, CA).
Acknowledgements
This work was supported by the fund from National Nature Science foundation
of China (No. 81370818).
Author details
1Department of Nephrology, Union Hospital, Tongji Medical College,
Huazhong University of Science and Technology, 430022 Wuhan, China.
2Department of Trauma Surgery, Tongji Hospital, Tongji Medical College,
Huazhong University of Science and Technology, 430030 Wuhan, China.
3Department of Rheumatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen
University, 510120 Guangzhou, China. 4Department of Medicine, University of
California, San Francisco, CA 94107-2140, USA. 5Department of Molecular and
Cellular Pharmacology, University of California, San Francisco, CA 94107-2140,
USA
Conflict of interest
The authors declare that they have no conflict of interest.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Received: 20 June 2018 Revised: 27 September 2018 Accepted: 18 October
2018
References
1. Nagata, M. Podocyte injury and its consequences. Kidney Int. 89, 1221–1230
(2016).
2. Mundel, P. Podocyte biology and response to injury. J. Am. Soc. Nephrol. 13,
3005–3015 (2002).
3. Pavenstadt, H., Kriz, W. & Kretzler, M. Cell biology of the glomerular podocyte.
Physiol. Rev. 83, 253–307 (2003).
4. Peng, L. et al. Lack of serum- and glucocorticoid-inducible kinase 3 leads
to podocyte dysfunction. FASEB J. 32, 576–587 (2018).
5. Li, C., Ge, Y., Dworkin, L., Peng, A. & Gong, R. The β isoform of GSK3 mediates
podocyte autonomous injury in proteinuric glomerulopathy. J. Pathol. 239,
23–35 (2016).
6. Li, C., Ge, Y., Peng, A. & Gong, R. The redox sensitive glycogen synthase
kinase 3beta suppresses the self-protective antioxidant response in podocytes
upon oxidative glomerular injury. Oncotarget 6, 39493–39506 (2015).
7. Lang, F. et al. (Patho)physiological significance of the serum- and
glucocorticoid-inducible kinase isoforms. Physiol. Rev. 86, 1151–1178 (2006).
8. Wang, X. et al. Interplay between the Notch and PI3K/Akt pathways in high
glucose-induced podocyte apoptosis. Am. J. Physiol. Renal Physiol. 306,
F205–F213 (2014).
9. Tejada, T. et al. Failure to phosphorylate AKT in podocytes from mice with
early diabetic nephropathy promotes cell death. Kidney Int. 73, 1385–1393
(2008).
10. Canaud, G. et al. AKT2 is essential to maintain podocyte viability and function
during chronic kidney disease. Nat. Med. 19, 1288–1296 (2013).
11. Arencibia, J. M., Pastor-Flores, D., Bauer, A. F., Schulze, J. R. O. & Biondi, R. M.
AGC protein kinases: From structural mechanism of regulation to allosteric
drug development for the treatment of human diseases. Biochim. Biophys.
Acta 1834, 1302–1321 (2013).
12. Kerjaschki, D., Sharkey, D. J. & Farquhar, M. G. Identification and characterization
of podocalyxin–the major sialoprotein of the renal glomerular epithelial cell.
J. Cell. Biol. 98, 1591–1596 (1984).
Yuan et al. Cell Death and Disease          (2018) 9:1114 Page 15 of 16
Official journal of the Cell Death Differentiation Association
13. Sawada, H., Stukenbrok, H., Kerjaschki, D. & Farquhar, M. G. Epithelial
polyanion (podocalyxin) is found on the sides but not the soles of
the foot processes of the glomerular epithelium. Am. J. Pathol. 125, 309–318
(1986).
14. Doyonnas, R. et al. Anuria, omphalocele, and perinatal lethality in mice lacking
the CD34-related protein podocalyxin. J. Exp. Med. 194, 13–27 (2001).
15. Ikenouchi, J., Hirata, M., Yonemura, S. & Umeda, M. Sphingomyelin
clustering is essential for the formation of microvilli. J. Cell. Sci. 126, 3585–3592
(2013).
16. Tesar, V. & Zima, T. Recent progress in the pathogenesis of nephrotic pro-
teinuria. Crit. Rev. Clin. Lab. Sci. 45, 139–220 (2008).
17. Takeda, T. Podocyte cytoskeleton is connected to the integral membrane
protein podocalyxin through Na+/H+-exchanger regulatory factor 2 and
ezrin. Clin. Exp. Nephrol. 7, 260–269 (2003).
18. Schmieder, S., Nagai, M., Orlando, R. A., Takeda, T. & Farquhar, M. G. Podoca-
lyxin activates RhoA and induces actin reorganization through NHERF1 and
Ezrin in MDCK cells. J. Am. Soc. Nephrol. 15, 2289–2298 (2004).
19. Hara, M. et al. Urinary podocalyxin is an early marker for podocyte injury in
patients with diabetes: establishment of a highly sensitive ELISA to detect
urinary podocalyxin. Diabetologia 55, 2913–2919 (2012).
20. Asao, R. et al. Relationships between levels of urinary podocalyxin, number of
urinary podocytes, and histologic injury in adult patients with IgA nephro-
pathy. Clin. J. Am. Soc. Nephrol. 7, 1385–1393 (2012).
21. Kawaguchi, K., Yoshida, S., Hatano, R. & Asano, S. Pathophysiological roles of
ezrin/radixin/moesin proteins. Biol. Pharm. Bull. 40, 381–390 (2017).
22. Morales, F. C., Takahashi, Y., Kreimann, E. L. & Georgescu, M. M. Ezrin-radixin-
moesin (ERM)-binding phosphoprotein 50 organizes ERM proteins at the
apical membrane of polarized epithelia. Proc. Natl Acad. Sci. USA 101,
17705–17710 (2004).
23. Nielsen, J. S. et al. The CD34-related molecule podocalyxin is a potent inducer
of microvillus formation. PLoS ONE 2, e237 (2007).
24. Takeda, T., McQuistan, T., Orlando, R. A. & Farquhar, M. G. Loss of glomerular
foot processes is associated with uncoupling of podocalyxin from the actin
cytoskeleton. J. Clin. Invest. 108, 289–301 (2001).
25. Lamothe, S. M. & Zhang, S. Chapter Five - Ubiquitination of ion channels and
transporters. Prog. Mol. Biol. Transl. Sci. 141, 161–223 (2016).
26. Foot, N., Henshall, T. & Kumar, S. Ubiquitination and the regulation of mem-
brane proteins. Physiol. Rev. 97, 253–281 (2017).
27. Yang, B. & Kumar, S. Nedd4 and Nedd4-2: closely related ubiquitin-protein
ligases with distinct physiological functions. Cell Death Differ. 17, 68–77 (2010).
28. Hugo, C. et al. The plasma membrane-actin linking protein, ezrin, is a glo-
merular epithelial cell marker in glomerulogenesis, in the adult kidney and in
glomerular injury. Kidney Int. 54, 1934–1944 (1998).
29. Ostalska-Nowicka, D. Ezrin–a useful factor in the prognosis of nephrotic syn-
drome in children: an immunohistochemical approach. J. Clin. Pathol. 59,
916–920 (2006).
30. Tao, H. et al. Cyclic AMP prevents decrease of phosphorylated ezrin/radixin/
moesin and chloride intracellular channel 5 expressions in injured podocytes.
Clin. Exp. Nephrol. 19, 1000–1006 (2015).
31. Mo, H. et al. C-X-C chemokine receptor type 4 plays a crucial role in mediating
oxidative stress-induced podocyte injury. Antioxid. Redox Signal. 27, 345–362
(2017).
32. Bhalla, V. et al. Serum- and glucocorticoid-regulated kinase 1 regulates
ubiquitin ligase neural precursor cell-expressed, developmentally down-
regulated protein 4-2 by inducing interaction with 14-3-3. Mol. Endocrinol. 19,
3073–3084 (2005).
33. Arroyo, J. P. et al. Nedd4-2 modulates renal Na+-Cl- cotransporter via the
aldosterone-SGK1-Nedd4-2 pathway. J. Am. Soc. Nephrol. 22, 1707–1719
(2011).
34. Xu, J., Liu, D., Gill, G. & Songyang, Z. Regulation of cytokine-independent
survival kinase (CISK) by the Phox homology domain and phosphoinositides.
J. Cell. Biol. 154, 699–706 (2001).
35. Liu, D., Yang, X. & Songyang, Z. Identification of CISK, a new member of
the SGK kinase family that promotes IL-3-dependent survival. Curr. Biol. 10,
1233–1236 (2000).
36. Fehon, R. G., McClatchey, A. I. & Bretscher, A. Organizing the cell cortex: the
role of ERM proteins. Nat. Rev. Mol. Cell Biol. 11, 276–287 (2010).
37. Wasik, A. A. et al. Ezrin is down-regulated in diabetic kidney glomeruli
and regulates actin reorganization and glucose uptake via GLUT1 in cultured
podocytes. Am. J. Pathol. 184, 1727–1739 (2014).
38. Bautista-Garc a, P. et al. Zona occludens-2 protects against podocyte
dysfunction induced by ADR in mice. Am. J. Physiol. Ren. Physiol. 304, F77–F87
(2013).
39. Zhou, L. et al. Mutual antagonism of Wilms’ tumor 1 and beta-catenin dictates
podocyte health and disease. J. Am. Soc. Nephrol. 26, 677–691 (2015).
40. Zhou, L. et al. Multiple genes of the renin-angiotensin system are novel targets
of Wnt/beta-catenin signaling. J. Am. Soc. Nephrol. 26, 107–120 (2015).
41. Pawluczyk, I. Z. A. et al. Sialic acid attenuates puromycin aminonucleoside-
induced desialylation and oxidative stress in human podocytes. Exp. Cell Res.
320, 258–268 (2014).
42. Krishnamurti, U. et al. Puromycin aminonucleoside suppresses integrin
expression in cultured glomerular epithelial cells. J. Am. Soc. Nephrol. 12,
758–766 (2001).
43. Liu, X. et al. Orthogonal ubiquitin transfer identifies ubiquitination substrates
under differential control by the two ubiquitin activating enzymes.
Nat. Commun. 8, 14286 (2017).
44. Zaarour, R. F. et al. Ezrin ubiquitylation by the E3 ubiquitin ligase, WWP1,
and consequent regulation of hepatocyte growth factor receptor activity.
PLoS ONE 7, e37490 (2012).
45. Wang, H. et al. GIV/girdin links vascular endothelial growth factor signaling
to Akt survival signaling in podocytes independent of nephrin. J. Am. Soc.
Nephrol. 26, 314–327 (2015).
Yuan et al. Cell Death and Disease          (2018) 9:1114 Page 16 of 16
Official journal of the Cell Death Differentiation Association
